Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook

Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The survival rate for TNBC is generally worse than other breast cancer subtypes. TNBC treatment has made significant advances, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Obidiro, Onyinyechi, Battogtokh, Gantumur, Akala, Emmanuel O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384267/
https://www.ncbi.nlm.nih.gov/pubmed/37513983
http://dx.doi.org/10.3390/pharmaceutics15071796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384267/
https://www.ncbi.nlm.nih.gov/pubmed/37513983
http://dx.doi.org/10.3390/pharmaceutics15071796

Ejemplares similares